Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE Evidence is presented that the expression levels of aldehyde dehydrogenase 2 family member, cytochrome P450 family 2 subfamily C member 8, alcohol dehydrogenase 4 (class II), pi polypeptide, alcohol dehydrogenase 1B (class I), β polypeptide and cytochrome P450 family 2 subfamily C member 9 were associated with the overall survival of patients with HCC and that the expression levels of pituitary tumor‑transforming 1, cell division cycle 20, DNA topoisomerase II α and cyclin B2 were negatively associated with the overall survival of patients with HCC. 30720105 2019
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE The cytochrome P450 2B6 and 3A4-inductive effects were studied using promoter reporter assays in human hepatocarcinoma cells. 29949932 2018
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma. 30280198 2018
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease CTD_human Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. 28284560 2017
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE To avoid hepatocyte lot-to-lot variability, we assessed CYP2C8 regulation by MC in HepaRG cells, a terminally differentiated human hepatocellular carcinoma cell line that maintains high P450 expression. 28384415 2017
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE However, BRCA1-stimulated network contained BRCA1 activation with endothelium-specific to lysosomal transmembrane and carbamoyl synthetase to tastin, histone cluster and cyclin-induced growth, whereas the corresponding inhibited different complete network included BRCA1 repression with ovalbumin, thyroid stimulating hormone beta and Hu antigen C to cytochrome P450 to transducin-induced inflammation in higher HCC. 24151232 2014
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE The use of hepatoma cell lines, such as HepG2 cell line, for the evaluation of drug-induced hepatotoxicity is hampered by their low cytochrome P450 expression which makes impossible the study of the toxicity produced by bioactivable compounds. 22138474 2012
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE In addition, an association of JNK1 activation with the histone H3 lysines 4 and 9 tri-methylation was observed in the HCC tissues, which leads to an elevated expression of genes regulating cell growth and a decreased expression of the genes for cell differentiation and the p450 family members in HCC. 19041150 2009
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease LHGDN ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses. 18332083 2008
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. 16077914 2005
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma. 16048566 2005
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE To investigate whether arsenic exposure in utero causes altered estrogen signaling, we examined expression of estrogen receptor-alpha (ER-alpha), cyclin D1 (an estrogen-responsive hepatic oncogene), and several cytochrome P450 genes (with sexually dimorphic liver expression patterns) in livers from adult male mice with in utero arsenic-induced HCC. 15026472 2004
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE This is associated with dramatic tumor reduction of diffuse HCC after a single intravascular administration of rRp450. rRp450 holds the promise of the dual therapeutic benefit of selective oncolysis and P450 transgene delivery. 10850415 2000
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE Failure of Ah receptor to mediate induction of cytochromes P450 in the CYP1 family in the human hepatoma line SK-Hep-1. 11147830 2000
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE The genetically engineered V79MZh1A1 cell line with stable expression of cDNA of human cytochrome P4501A1, the parental V79MZ cell line lacking any cytochrome P450 activity and human hepatocarcinoma Hep G2 cells were used as a model cells. 10984687 2000
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE Eight cDNAs encoding galectin 4 (Gal-4), UGT2B4 (UDP-glucuronosyltransferase), ribosomal phosphoprotein P0 (rpP0), dek, insulin-like growth factor binding protein (IGFBP) 1, vitronectin, retinoic acid-induced gene E (RIG-E), and CYP3A4 (cytochrome P450 nifedipine oxidase) were identified as differentially expressed genes between human hepatocellular carcinoma (HCC) and matched nontumorous liver tissues. 10519413 1999
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 AlteredExpression disease BEFREE Promoters I.3 and II were used for P450arom gene expression in the hepatocellular cancer tissue. 9589695 1998
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE Twelve forms of human cytochrome P450 were synthesized in human hepatoma Hep G2 cells by means of cDNA-directed expression using vaccinia virus. 2161748 1990
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.400 Biomarker disease BEFREE Microsomal enzyme activities characteristic of cytochromes P450 and P448 and epoxide hydrolase were examined in the two hepatoma cell lines and compared to levels in rat liver microsomal preparations. 6682173 1983